C6orf130 anticorps (AA 51-150) (Cy3)

N° du produit ABIN1702913

Détail du produit anti-C6orf130 anticorps (Cy3)

Antigène: C6orf130 (OARD1) (O-Acyl-ADP-Ribose Deacylase 1 (OARD1))

Épitope: AA 51-150

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp C6orf130 est conjugé à/à la Cy3

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Homologie: Human,Mouse,Rat,Dog,Pig,Horse,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human C6orf130

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur C6orf130

Antigène: C6orf130 (OARD1) (O-Acyl-ADP-Ribose Deacylase 1 (OARD1))

Autre désignation: C6orf130 (OARD1 Produits)

Synonymes: anticorps C23H6orf130, anticorps C6orf130, anticorps TARG1, anticorps dJ34B21.3, anticorps AI314976, anticorps AW558560, anticorps O-acyl-ADP-ribose deacylase 1, anticorps OARD1, anticorps Oard1

Sujet:

Synonyms: C6orf130, OARD1_HUMAN, Chromosome 6 open reading frame 130, dJ34B21.3, O acetyl ADP ribose deacetylase C6orf130, Uncharacterized protein C6orf130.

Background: C6orf130 is a Making up nearly 6 % of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposes an individual to developing this porphyria. Notably, the PARK2 gene, which is associated with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf130 gene product has been provisionally designated C6orf130 pending further characterization.

ID gène: 221443